chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Hair falling out/Receiving hairline in the right side of her head; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (Hair falling out/Receiving hairline in the right side of her head) and PAIN IN EXTREMITY (Sore arm) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 088D21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (twice but not enough to be hospitalize), Cough (Patient state for 3 straight months she was cough badly), Taste abnormality and Smell change. Concomitant products included METOPROLOL for an unknown indication.    On 18-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Oct-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 24-Oct-2021, the patient experienced ALOPECIA (Hair falling out/Receiving hairline in the right side of her head). At the time of the report, ALOPECIA (Hair falling out/Receiving hairline in the right side of her head) and PAIN IN EXTREMITY (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient states that The first shot made hair fall out and supposed to get the second. As a woman, don't want to be bald.   Most recent FOLLOW-UP information incorporated above includes: On 15-Nov-2021: followup document contains non-significant information
only experienced soreness at the site; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of injection site pain in a patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis.   Previously administered products included Flu shot with an associated reaction of injection site pain.   On an unknown date, the patient received RSV vaccine. On an unknown date, an unknown time after receiving RSV vaccine, the patient experienced injection site pain (Verbatim: only experienced soreness at the site).The outcome of the injection site pain was not reported.   It was unknown if the reporter considered the injection site pain to be related to RSV vaccine.  It was unknown if the company considered the injection site pain to be related to RSV vaccine.   Additional Information: GSK Receipt Date: 15-SEP-2023 This case was reported by a patient via interactive digital media. The patient got his/her RSV vaccine and only experienced soreness at the site just like with the flu shot.
MA reporting giving 3rd dose; This case was reported by a other health professional via call center representative and described the occurrence of extra dose administered in a 16-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA654A, expiry date unknown) for prophylaxis.   On 14th May 2022, the patient received Menveo. On 14th May 2022, unknown after receiving Menveo, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown.   Additional Information: GSK Receipt Date: 16-MAY-2022 Reporters comment: Medical assistant reporting giving 3rd dose of Menveo to the patient. Healthcare professional did not have expiration date available.  Adverse event report contained all reported adverse event information by healthcare professional at the time of reporting.  Healthcare professional gave consent for safety to follow up. Additional supportive information: The patient received 3rd dose of Menveo, which led to extra dose administered.
Irregular, abnormal breakthrough bleeding/spotting between periods and an abnormally timed period after vaccination (period began only three weeks into cycle).
approximately 5pm my heart started RACING.  similar to when I have one of my irregular heartbeat episodes.  i laid down and relaxed.  usually they will stop within 1 hour.  this was different, it continued all night, weakening me as the night progressed.  i stayed in bed hoping i wasn't having a heart attack, ready to call an ambulance if necessary.  after quite a few hours, it subsided and my heartbeat went back to normal.  it was a very scary event.
weakness all over; had projectile vomiting along with horrible pain in her stomach and liver area; had projectile vomiting along with horrible pain in her stomach and liver area; having a fever of 101; had projectile vomiting along with horrible pain in her stomach and liver area; This non-serious case was reported by a consumer via call center representative and described the occurrence of weakness generalized in a 70-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   On 03-SEP-2023, the patient received the 1st dose of Arexvy (intramuscular, right deltoid). On 03-SEP-2023, less than a day after receiving Arexvy, the patient experienced weakness generalized (Verbatim: weakness all over), hepatic pain (Verbatim: had projectile vomiting along with horrible pain in her stomach and liver area), vomiting projectile (Verbatim: had projectile vomiting along with horrible pain in her stomach and liver area), fever (Verbatim: having a fever of 101) and stomach pain (Verbatim: had projectile vomiting along with horrible pain in her stomach and liver area).  On 05-SEP-2023, the outcome of the hepatic pain, vomiting projectile, fever and stomach pain were resolved (duration 2 days). The outcome of the weakness generalized was not resolved.   It was unknown if the reporter considered the weakness generalized, hepatic pain, vomiting projectile, fever and stomach pain to be related to Arexvy.     It was unknown if the company considered the weakness generalized, hepatic pain, vomiting projectile, fever and stomach pain to be related to Arexvy.   Additional Information: GSK Receipt date: 05-SEP-2023 The patient self-reported this case.  The symptoms started on the day of the vaccination and the patient complains of fever of 101 that had now resolved.  The reporter also stated that she had projectile vomiting along with horrible pain in her stomach and liver area that had now both resolved.  The reporter stated that she had weakness, and this symptom was ongoing and she had not stated any of this to the HCP (healthcare professional) but will do so.
Sore arm, neck and lower back Lots of pressure in head and behind eyes Chills Took  400mg advil 12 hours and 16 hours after onset of symptoms
Patient got fainted after a Dose of Twinrix and Fluvirin injected separately.
(R) thigh red and hard 24 hours after admin. UC on Sunday due to double in size.
Patient was seen at urgent care on 7/13/22 for cough, congestion, and fatigue and tested positive. She presented to the hospital on 7/16/22 to deliver her baby at 38 weeks 5 days. The baby was born on 7/17/22 and weighed 3.74 kg. During pregnancy, the patient had gestational diabetes and hypothyrodism
11 days after vaccination my arm is itchy around the injection site and I have a red raised rash.
Swollen left deltoid muscle 9-10cm. Treated with Benadryl by mouth an cool compresses.
Patient called the health department around 2:45 reporting she had broke out in rash on entire face that had moved down to her chest. Patient reported getting the Covid-19 vaccination at 1:00 Pm today . Recommended patient to follow up with ER or PCP for allergic reaction today .
This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Knee pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced ARTHRALGIA (Knee pain). At the time of the report, ARTHRALGIA (Knee pain) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in. No concomitant medication information was provided. It was unknown if patient was enrolled in a COVID-19 vaccine trial. No treatment medication was provided.
At approx 10:10AM client was at receptionists desk et fell to floor. No s/s of injuries noted. Cool rag/water given.
pt recv vax & 02JUN94 pt devel swelling & redness of the hands & feet; the palms of hands & feet were very itchy; mom treated pt w/DPH & pt recovered the same day;
patient is experiencing a shingles rash; This is a spontaneous report from a contactable pharmacist. A female patient of unknown age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: UNKNOWN) via an unspecified route of administration on an unspecified as single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. It was reported that patient had gotten the Moderna vaccine. On an unspecified date, patient experienced shingles rash. Reporter wanted to know if the patient can get the second dose on 08April. Outcome of the event was unknown.  Follow-up attempts are completed. No further information is expected.
A persistent sore spot on left rib cage, after vaccine, building to a case of full blown Lyme Disease on 1/30/2000, with possible immune problems. Disabled with multiple symptoms. 60 Day FU states has not been able to work since 1/30/00, severe fatigue, knee, hip, and elbow and finger pain. Lost 25 pounds, lost all muscle tone, short term memory loss, muscle twitches in legs, buttocks, and arms. Hearing and light sensitivity
The pt experienced a high fever of 104 - 105 for 48 hours. Possible febrile seizure.
This spontaneous report as received from two healthcare workers refers to a 3 month old patient of unknown gender. Pertinent medical history and drug reactions/allergies were not reported. On 18-FEB-2016 the patient was inadvertently vaccinated with VAQTA (dose was not reported, lot # was reported as L038018 and expiration date was reported as 13-SEP-2017) intramuscularly (inappropriate schedule of drug administration). Concomitant drug was not reported. No adverse event was reported. Lot # L038018 was invalid for VAQTA. Additional information has been requested.
Headache, Myalgia, Fever,  SORE ARM; CHILLS Narrative:
COVID19 POSITIVE BY PCR ON 12/7/21. SYMPTOMATIC. ADMITTED TO ICU.  PT REQUIRED CPAP, INTUBATION.  PATIENT DIED 12/21/2021
Rash / hives, itching on arms legs stomach back hands feet 02/22/2018 at 6:30 am.
swollen and irritated lips and eyes, started 24 hours after vaccine 3/5, took over the counter Benadryl and called my primary care's office on Monday 3/8
Patient received MMR #2. Within 15 minutes of getting the vaccine, her face was red, around her eyes were swollen. She was not acting herself, more tired. Her whole body then turned red. She was brought back to the office immediately. She was given BENADRYL and observed in the office.  She had no difficulty breathing. No swelling of lips. Prior to leaving the office, she was slightly more interactive and the rash was not worsening. At home, mom observed some tic-like movements, no seizures, that resolved. She was brought back into the office and was noted to have hives all over her body. These resolved that day. No symptoms since.
Patient said she got hives 2 weeks after J&J. Discussed with doctor and told to get Moderna.
lump (presumed sterile abscess) devel p/vax 21MAR97 became secondarily infected NOV97; needed I&D surgery;site of 2 shots DTAP & HIB combined in 1 syringe;
arm tenderness, bad aches in all muscles, high fever and chills, nausea and vomiting, severe headache for the following 18 hours  Days later developed facial drooping/weakness.   Tylenol-Motrin Tested for Covid.
During night on day of injection I experienced chilling, sore arm which continued into the next day. I had a low grade fever of 99.3, chills, headache & joint pain into the evening of the next day. Felt normal 2 days after injection.
Pt received 1st Pfizer vaccine and at his followup appt he received Moderna
Pain at shot site, chills, low blood pressure, rapid pulse. felling better now. went to doctor was diagnosed with atrial flutter. still gets out of breath and blood pressure jumps around.
Patient received 1st GARDASIL imm. on Jan. 5, 2011. On Jan. 11 developed a rash on both arms & chest. Took BENADRYL to alleviate itching. Jan. 13, noticed spots had appeared in rash area. Other symptoms Jan. 11-14 included shaky hands, hands were achy, fatigue, loss of appetite & nausea. Rash disappeared Jan. 15 but fatigue & nausea continue. Patient had used tanning bed during the time rash appeared.
Information has been received from a Licensed practical nurse referring to unspecified patients of unknown age and gender. On unknown date the patients were vaccinated with improperly stored doses of PNEUMOVAX 23 (Lot # M000592 with expiration date of 12-Oct-2017; strength, dosage, frequency and route unspecified). Temperature was 49 F and time frame was total cumulative 84 minutes. No adverse event was reported. This is one of several reports received from the same reporter. Additional information has been requested.
very difficult to walk,difficult time getting to bathroom; difficlty to speech; incontinence; 102 temp; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (very difficult to walk,difficult time getting to bathroom), SPEECH DISORDER (difficlty to speech), INCONTINENCE (incontinence) and PYREXIA (102 temp) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced GAIT DISTURBANCE (very difficult to walk,difficult time getting to bathroom), SPEECH DISORDER (difficlty to speech), INCONTINENCE (incontinence) and PYREXIA (102 temp). At the time of the report, GAIT DISTURBANCE (very difficult to walk,difficult time getting to bathroom), SPEECH DISORDER (difficlty to speech), INCONTINENCE (incontinence) and PYREXIA (102 temp) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication was reported.  No concomitant medication was reported   Reporter did not allow further contact
Bell's Palsy begun 18MAR93 (3 days p/2nd inoculation);
Pt came on 11/22/22 to get covid booster was given 0.25 mL should have been given 0.5 mL. Will return in 2 month for full dose.
Onset of chills and fever to 101.5 about 11 hours after injection. Responded well to OTC Acetaminophen. 18 hours later, chills, fatigue and temperature returned, responded to Acetaminophen. Persistent night sweats for 5 consecutive nights.
3rd or 4th day after shot: Extreme fatigue, severe weakness, shakiness, especially in lower extremities. Often trembly with complete lack of appetite (lost 6 pound in 2 weeks). Only wanted to sit or lie down- unable to  go for daily walk (no strength).  No fever or respiratory symptoms.  This extreme condition lasted for approx. 10 weeks, during which time I saw my doctors five times for diagnosis or assistance.  They could find no reason for my sudden symptoms except for adverse reaction to the vaccine, and were unable to assist.  I mostly sat and laid around  for 10/11 weeks , after which my symptoms improved gradually, and I  am feeling better at this time.
pt recv vax 30JUN97 & 28AUG7 revealed a titer of 0.71;
Client c/o some itching a few minutes after shot. no redness, ice was applied to site and that stopped itching. On 11-06-01, arm was little sore , but still some soreness.
The patient received the Vaccine on 10/11. On 10/12 the patient took her Band-Aid off and noticed her arm was red around the area. On 10/13 the patient noticed the area was red and raised below the injection site. On 10/12 the patient took some TYLENOL but if did not help so she took MOTRIN. On 10/13 the patient tried to use Hydrocortisone cream but it did not help and also by mouth BENADRYL to help. She experienced soreness around the injection site and area under injection site. On 10/15 the patient noticed the swelling had gone down and redness. On 10/16 the patient called the pharmacy to inform us and she is still experiencing some soreness with a pain level of 2 or 3.
Patient report itchy skin, not on the injection site, reports that is on forearms and stomach area
SUSPECTED CLINICAL VACCINATION FAILURE; SUSPECTED COVID-19 INFECTION; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included tested positive for covid. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) frequency 1 total, dose was not reported, administered on 21-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 06-MAY-2021, the patient tested positive for Covid-19. His symptoms were mild and he was self-isolating (coded as suspected clinical vaccination failure and suspected covid-19 infection). The testing facility never asked the patient whether he had been vaccinated. Laboratory data included: COVID-19 virus test (NR: not provided) positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the suspected covid-19 infection and suspected clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with product quality complaint :90000178874.; Sender's Comments: V0- 20210516365-covid-19 vaccine ad26.cov2.s -Suspected clinical vaccination failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS
Patient received Bivalent Booster of Pfizer for the first shot in her primary series.  instead of the original Monovalent Vaccine.  Patient did not report any Adverse Reactions
Shoulder was so sore, I could barely lift it. On Monday, I returned to the same clinic on Monday (9/10/2012) due to continued flu symptoms and to complain of significant shoulder pain.
fever (99.3); Nausea; vomiting; diarrhea; fatigue; headache; This is a spontaneous report from a contactable other hcp. A 39-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN6202, Expiration date was not reported), dose 1 via an unspecified route of administration, administered in Arm Left on 26Feb2021 14:45 (age at vaccination 39 years) as dose 1, single for covid-19 immunisation. Medical history included asthma, migraine. Concomitant medication(s) included melatonin (MELATONIN); amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) XR 30mg; vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]); vitamin d nos (VITAMIN D NOS). The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 27Feb2021 23:00 the patient experienced nausea, vomiting, diarrhea, fatigue, headache, fever (99.3). The patient underwent lab tests and procedures which included body temperature: 99.3 on 28Feb2021 (fever (99.3) 36 hours after administration of vaccine). The patient did not received treatment for reported events. The outcome of event was recovering.  No follow-up attempts are possible; No further information is expected.
Mid-December, (months later) pain in left arm bicep, pain got worse, couldn't move in certain ways, without extreme pain. Couldn't reach behind my back or to the side. Pain got worse, mobility got less. At end of January went to Rehab. Found bone spur and inflammation. Got shot of steroid. Recommended PT. 7 PT sessions, during therapy, developed right arm symptoms. Got PT on both arms. Able to increase mobility in arms. Follow-up in a month. After 7 PT sessions. Got another steroid shot. Prescribed 100 mg Advil 3x day. Next appt. In May. Still in constant pain.
Client received the COVID vaccine (Pfizer dose 2, lot #EW0179, expiration 4/28/2021) at 1525. Client reported "a spot of numbness" on his tongue at 1544, RNs, PHN, responded at that time. The client's subjective symptoms were similar to what happened 30 minutes after his first dose, per the client, and they resolved after 1 hour that time. The client did not appear to be in distress, had no visible swelling or redness on his face, tongue, or lips, and complained of no shortness of breath. O2 was 98% and heart rate was 86. The client takes no medications and has no medical history. The client's only allergy was a childhood allergy to bees with a localized reaction, that has since resolved as an adult. At 1550, the client stated that the numbness had started to improve and deferred benadryl at that time. At 1553, the client's blood pressure was 130/100 using the automatic cuff. At 1556, the client's repeat blood pressure was 127/98, with an O2 of 97, respiratory rate of 14, and heart rate of 81. At 1605, the client's blood pressure was 136/115 on the automatic cuff, with O2 98 and heart rate 87. The client had a bright affect and was conversational with staff. At 1615, the client stated he felt "good" and was comfortable driving home. The final vital signs for the client were blood pressure 140/97, heart rate 88, and O2 98%. Education provided regarding v-safe, primary care follow up, emergency management, and AMR activation.
1:50pm Client complained of feeling hot, "burning up", heart racing, and became very weak unable to sit up in chair. O2 sat 99%. Client assisted to floor in supine position, ice packs applied, VS stable, EMS ordered epi pen 0.3mg IM left thigh and Benadryl 50mg rt deltoid. AAOx3, IV Normal Saline admin, and client transferred to local hospital at 2:10PM.
This spontaneous report was received from a physician and refers to an over 75 year old male patient enrolled in message testing. No information regarding the patient's medical history, concurrent conditions and concomitant medication was reported. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX, subcutaneous (dose, lot # and expiration date were not provided). On an unknown date (in last 4 years), the patient had very mild case of shingles even after having ZOSTAVAX. The physician attributed that this case was mild because of the vaccination and would have expected much worse without having it. The patient recovered from the shingles on an unknown date. The outcome of vaccination failure was unknown. The reporter considered the shingles to be not related to ZOSTAVAX. The relatedness between vaccination failure and ZOSTAVAX was not reported. This is one of two reports received from the same source. Additional information is not expected as there was no consent to contact the physician.
Pt complained of swelling of feet and hands; pain in right arm and down right leg; stiffness and pain in neck. Later in the evening, she took Aleve and noticed swelling in hands and ankles and feet right after taking Aleve. She used ice-packs on feet and ankles and swelling went down a little. The next day, it increased. She noticed swelling in joints of wrists, knees, ankles, hands and feet; also ached. Lasted until 8/26/01 and slowly went away. Received 1st and 2nd dose of Hep-B with no side effects.